Biologic Response Modifiers

Biologic Response Modifiers is a class of therapeutic agents that modulate the immune system by selectively targeting specific components of the immune response, such as cytokines or immune cells, to alter disease progression in conditions like autoimmune disorders or cancer.

416

Publications

20.1K

Citations

1.8K

Authors

532

Institutions

Publications per year

2017–2026

15

Variants

Biological Response ModifiersBrms

Authors

1.8K

  1. JE
    James E. Talmadge

    University of Nebraska Medical Center, United States

    11 publications · 621 citations

    10

    h-index

  2. RH
    Robert H. Wiltrout

    National Cancer Institute, United States

    7 publications · 584 citations

    7

    h-index

  3. RB
    Ronald B. Herberman

    National Cancer Institute, United States

    7 publications · 399 citations

    7

    h-index

  4. MA
    Michael A. Chirigos

    National Cancer Institute, United States

    6 publications · 154 citations

    6

    h-index

  5. WJ
    Walter J. Urba

    Providence Portland Medical Center, United States

    6 publications · 221 citations

    6

    h-index

1–5 of 1.8K

Venues

  1. PubMed

    Repository · 85 publications · 3K citations

    31

    h-index

  2. The Journal of Immunology

    JI · 14 publications · 1.1K citations

    14

    h-index

  3. Cancer

    12 publications · 382 citations

    11

    h-index

  4. JNCI Journal of the National Cancer Institute

    10 publications · 549 citations

    10

    h-index

  5. Journal of Leukocyte Biology

    JLB · 9 publications · 220 citations

    9

    h-index

1–5